Purchase Order 75N95021P00063
Award Date
12/31/20
Potential Completion Date
12/31/24
Potential Value
$2.1M
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Avista Pharma Solutions, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27713, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Medical Science & Computing, LLC has been awarded a $3.1 million firm fixed price delivery order by the Department of Health and Human Services' National Institutes of Health Office of Logistics and Acquisition Operations to provide CGMP manufacture of GS-441524 for the National Center for Advancing Translational Sciences' Division of Preclinical Innovation and Testing's Therapeutics for Rare and Neglected Diseases program. The contract runs from April 2021 through December 2023 for the...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $10,465 firm fixed price purchase order to Cambrex High Point, Inc. to support retesting of the GLWL-01 reference standard and project specific funding. Cambrex will perform the work in Baltimore, Maryland over a one year period from July 2023 through July 2024. The National Institute on Drug Abuse conducts important biomedical research on drug abuse and addiction to improve...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to A1 Biochem Labs LLC, a small business, for the purchase of 34 intermediate chemical compounds in 5g quantities with purity greater than 95%. The total potential value of the award is $112,350.00. This requirement was set aside for total small business participation and is part of the agency's Coronavirus COVID-19...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $827,789 firm fixed price delivery order against its CRO Support for NCATS Drug Substance Development and Manufacture master IDIQ contract to Bachem Americas, Inc. to support the manufacture of 1 kg of CGMP L-ENK in support of the Center's drug substance development and manufacture program. Performance will take place in Torrance, California over a four-year...
This $113,163 federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences to MedChemExpress LLC, a New Jersey-based provider of biochemicals, bioactive compounds, peptides, and other life science research materials. The contract is for the delivery of 75 chemical compounds to support ongoing COVID-19 research. The award was made via a purchase order under a non-competitive combined...
This is a $65,777.67 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the Department of Health and Human Services, to Government Scientific Source Inc. (GSS), a small business, to provide a Chromium Next GEM cell library to characterize single cell response in a 3D lung model to SARS-CoV-2 (COVID-19). The purchase order was set aside for small businesses and was issued under simplified acquisition procedures. It is part...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $29,820 firm fixed price purchase order to Medchemexpress LLC to deliver forty-four bioactive compounds for replenishment and expansion of the Mechanism Interrogation PlatE 6.0 screening library. The compounds will support the Center's high-capacity robotic platform used to screen drug combinations and further its chemogenomic screening capabilities. Delivery...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $391,467 firm fixed price purchase order to Pointcare Systems Inc. R&D Division, doing business as Chirosolve, to acquire 97 specified chemical compounds for NCATS' pre-clinical library in support of its antiviral initiative. The solicitation sought quotes for delivery of the chemical compounds to locations in the United States by September 2022, with...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $562,720 cost-plus-fixed-fee delivery order to Curia Global Inc., doing business as Amri, for chemistry and manufacturing services in support of Task C10, the chemical synthesis and process optimization of STF-1759. The award was issued against the prime vendor's existing Nonclinical Services for Development of Interventional Agents...
This federal contract award, valued at $91,000.00, was issued by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Novotech Drug Development Consulting LLC, doing business as CBR International, LLC, a small business. The contract provides regulatory support services for a pre-Investigational New Drug (IND) application meeting with the U.S. Food and Drug Administration (FDA)...